Dopaminergic inhibition of catecholamine secretion from chromaffin cells: Evidence that inhibition is mediated by D4 and D5 dopamine receptors

Journal of Neurochemistry

Volumn 66, Issue 1, 1996, Pages 222-232

  Dahmer, Mary K ^a   Senogles, Susan E ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Adenylyl cyclase; Adrenal gland; Ca2+ uptake; PCR; Pertussis toxin

Indexed keywords

DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR; RECEPTOR SUBTYPE;

ADRENAL GLAND; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CATECHOLAMINE RELEASE; CHROMAFFIN CELL; DOPAMINERGIC TRANSMISSION; DRUG INHIBITION; ENZYME ACTIVITY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0030065550     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66010222.x     Document Type: Article

References (45)

1. Andersen P. H., Gingrich J. A., Bates M. D., Dearry A., Falardeau P., Senogles S. E., and Caron M. G. (1990) Dopamine receptor subtypes: beyond the D1/D2 classification. Trends Pharmacol. Sci. 11, 231-236.
2. Artalejo A. R., Garcia A. G., Montiel C., and Sanchez-Garcia P. (1985) A dopaminergic receptor modulates catecholamine release from the cat adrenal gland. J. Physiol. (Lond.) 363, 359-368.
3. Artalejo C. R., Ariano M. A., Perlman R. L., and Fox A. P. (1990) Activation of facilitation calcium channels in chromaffin cells by D1 dopamine receptors through a cAMP/protein kinase A-dependent mechanism. Nature 348, 239-242.
4. Ben-Jonathan N. (1985) Dopamine: a prolactin-inhibiting hormone. Endocr. Rev. 6, 564-589.
5. Bigornia L., Suozzo M., Ryan K. A., Napp D., and Schneider A. S. (1988) Dopamine receptors on adrenal chromaffin cells modulate calcium uptake and catecholamine release. J. Neurochem. 51, 999-1006.
6. Cheek T. R. (1989) Spatial aspects of calcium signalling. J. Cell Sci. 93, 211-216.
7. Dahmer M. K. and Perlman R. L. (1988) Insulin and insulin-like growth factors stimulate DNA synthesis in PC12 pheochromocytoma cells. Endocrinology 122, 2109-2113.
8. Dahmer M. K., Hart P. M., and Perlman R. L. (1990) Studies on the effect of insulin-like growth factor-I on catecholamine secretion from chromaffin cells. J. Neurochem. 54, 931-936.
9. Dannies P. S., Rudnick M. S., Fishkes H., and Rudnick G. (1984) Spiperone: evidence for uptake into secretory granules. Proc. Natl. Acad. Sci. USA. 81, 1867-1870.
10. Dearry A., Gingrich J. A., Falardeau P., Fremeau R. T. Jr., Bates M. D., and Caron M. G. (1990) Molecular cloning and expression of the gene for a human D1 dopamine receptor. Nature 347, 72-76.
11. 2+ messenger systems together reverse dopaminergic inhibition of prolactin release. Endocrinology 117, 439-446.
12. Delbeke D., Scammel J. G., Martinez-Campos A., and Dannies P. S. (1986) Dopamine inhibits prolactin release when cyclic adenosine 3′,5′-monophosphate levels are elevated. Endocrinology 118, 1271-1277.
13. Einhorn L. C., Gregerson K. A., and Oxford G. S. (1991) D2 dopamine receptor activation of potassium channels in identified rat lactotrophs: whole-cell and single-channel recording. J. Neurosci 11, 3727-3737.
14. 2+ channels by diphenylbutylpiperidine antipsychotics linked to inhibition of prolactin gene expression. J. Biol. Chem. 265, 16373-16379.
15. Enyeart J. J., Biagi B. A., and Mlinar B. (1992) Preferential block of T-type calcium channels by neuroleptics in neural crest-derived rat and human C cell lines. Mol. Pharmacol. 42, 364-372.
16. Galizzi J. P., Fosset M., Romey G., Laduron P., and Lazdunski M. (1986) Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors. Proc. Natl. Acad. Sci. USA 83, 7513-7517.
17. Ghosh A. and Greenberg M. E. (1995) Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 268, 239-246.
18. Giros B., Sokoloff P., Martres M.-P., Riou J.-F., Emorine L. J., and Schwartz J.-C. (1989) Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature 342, 923-926.
19. Gonzalez M. C., Artalejo A. R., Montiel C., Hervas P. P., and García A. G. (1986) Characterization of a dopaminergic receptor that modulates adrenomedullary catecholamine release. J. Neurochem. 47, 382-388.
20. 2+ uptake and catecholamine secretion in primary dissociated cultures of adrenal medulla. J. Neurochem. 39, 635-646.
21. Kebabian J. W. and Calne D. B. (1979) Multiple receptors for dopamine. Nature 277, 93-96.
22. Kebabian J. W., Agui T., van Oene J. C., Shigematsu K., and Saavedra J. M. (1986) The D1 dopamine receptor: new perspectives. Trends Pharmacol. Sci. 7, 96-99.
23. Kilpatrick D. L., Ledbetter F. H., Carson K. A., Kirshner A. G., Slepetis R., and Kirshner N. (1980) Stability of bovine adrenal medulla cells in culture. J. Neurochem. 35, 679-692.
24. Lacey M. G., Mercuri N. B., and North R. A. (1987) Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. J. Physiol. (Lond.) 392, 397-416.
25. 2+ currents in rat anterior pituitary cells. Neuron 8, 455-463
26. 3H] N-methylspiperone binding. J. Neurochem. 48, 631-635.
27. 2+ increases in rat lactotroph cells. J. Biol. Chem. 262, 13920-13927.
28. O'Dowd B. F. (1993) Structures of dopamine receptors. J. Neurochem. 60, 804-816.
29. O'Malley K. L., Harmon S., Tang L., and Todd R. D. (1992) The rat D4 dopamine receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system. New Biol. 4, 137-142.
30. Penberthy W. T. and Dahmer M. K. (1994) Insulin-like growth factor-I-enhanced secretion is abolished in protein kinase C-deficient chromaffin cells. J. Neurochem. 62, 1707-1715.
31. Prozialeck W. C. and Weiss B. (1982) Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships. J. Pharmacol. Exp. Ther. 222, 509-516.
32. 3H] spiperone. Biochem. Pharmacol. 36, 3707-3713.
33. Sah D. W. Y. and Bean B. P. (1994) Inhibition of P-type and N-type calcium channels by dopamine receptor antagonists. Mol. Pharmacol. 45, 84-92.
34. Salomon Y., Londos C., and Rodbell M. (1974) A highly sensitive adenylate cyclase assay. Anal. Biochem. 58, 541-548.
35. Schoors D. F., Vauquelin G. P., DeVos H., Smets G., Velkeniers B., Vanhaelst L., and Dupont A. G. (1991) Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells. Br. J. Pharmacol. 103, 1928-1934.
36. Sibley D. R. and Monsma F. J. Jr. (1992) Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 10, 74-77.
37. Sokoloff P., Giros B., Martres M. P., Bouthenet M. L., and Schwartz J.-C. (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347, 146-151.
38. Stoof J. C., Drukarch B., de Boer P., Westerink B. H. C., and Groenewegen H. J. (1992) Regulation of the activity of striatal cholinergic neurons by dopamine. Neuroscience 47, 755-770.
39. Tiberi M., Jarvie K. R., Silvia C., Falardeau P., Gingrich J. A., Godinot N., Bertrand L., Yang-Feng T. L., Fremeau R. T. Jr., and Caron M. G. (1991) Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1a receptor. Proc. Natl. Acad. Sci. USA 88, 7491-7495.
40. Unsicker K. and Muller T. H. (1981) Purification of bovine adrenal chromaffin cells by differential plating. J. Neurosci. Methods 4, 227-241.
41. Valerio A., Alberici A., Tinti C., Spano P., and Memo M. (1994) Antisense strategy unravels a dopamine receptor distinct from the D2 subtype, uncoupled with adenylyl cyclase, inhibiting prolactin release from rat pituitary cells. J. Neurochem. 62, 1260-1266.
42. Vallar L. and Meldolesi J. (1989) Mechanisms of signal transduction at the dopamine D2 receptor. Trends Pharmacol. Sci. 10, 74-77.
43. Van Tol H. H. M., Bunzow J. R., Guan H.-C., Sunahara R. K., Seeman P., Niznik H. B., and Civelli O. (1991) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350, 610-614.
44. Waymire J. C., Bennett W. F., Boehme R., Hankins L., Gilmer-Waymire K., and Haycock J. W. (1983) Bovine adrenal chromaffin cells: high yield purification and viability in suspension culture. J. Neurosci. Methods 7, 329-351.
45. Weiss B., Prozialeck W., Cimino M., Barnette M. S., and Wallace T. L. (1980) Pharmacological regulation of calmodulin. Ann. NY Acad. Sci. 356, 319-345.